For the year ending 2025-12-31, SMTI had $700,562 increase in cash & cash equivalents over the period. $2,160,979 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -37,568,047 |
| Depreciation and amortization | 3,945,965 |
| Asset impairment charges | 28,313,527 |
| Gain on disposal of property and equipment | 9,674 |
| Credit loss expense | 509,233 |
| Inventory obsolescence | 582,046 |
| Share-based compensation | 5,154,761 |
| Noncash lease expense | 525,372 |
| Share of losses from equity method investments | -952,466 |
| Back-end fee | 780,312 |
| Paid-in-kind interest | 2,199,613 |
| Accretion of finance liabilities | 148,179 |
| Amortization and write-off of debt issuance costs | 279,905 |
| Accounts receivable, net | 114,690 |
| Accounts receivable related parties | -40,566 |
| Inventory, net | 1,777,762 |
| Prepaid and other assets | -123,515 |
| Accounts payable | 813,999 |
| Accounts payable related parties | -5,913 |
| Accrued royalties and expenses | 292,195 |
| Accrued bonuses and commissions | 2,127,966 |
| Operating lease liabilities | -526,905 |
| Net cash provided by (used in) operating activities | 6,786,629 |
| Purchases of property and equipment | 4,625,650 |
| Proceeds from disposal of property and equipment | 60,000 |
| Purchases of intangible assets | 23,452 |
| Investment in equity securities | 8,262,642 |
| Carepics acquisition | 2,122,146 |
| Net cash used in investing activities | -14,973,890 |
| Loan proceeds, net of debt issuance costs of 228,183 in 2025 and 1,160,740 in 2024 | 12,021,817 |
| Pay off debt assumed in carepics acquisition | 1,650,000 |
| Net settlement of equity-based awards | -546,994 |
| Cash payment of finance and earnout liabilities | 937,000 |
| Net cash provided by financing activities | 8,887,823 |
| Net increase in cash | 700,562 |
| Cash, beginning of period | 15,878,295 |
| Cash, end of period | 16,578,857 |
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)